0001209191-23-027196.txt : 20230503
0001209191-23-027196.hdr.sgml : 20230503
20230503205354
ACCESSION NUMBER: 0001209191-23-027196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230320
FILED AS OF DATE: 20230503
DATE AS OF CHANGE: 20230503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valence Investments SPV IV LLC
CENTRAL INDEX KEY: 0001812080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 23886054
BUSINESS ADDRESS:
STREET 1: 590 MADISON AVENUE 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-521-4379
MAIL ADDRESS:
STREET 1: 590 MADISON AVENUE 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valence Investments SPV VI, LLC
CENTRAL INDEX KEY: 0001971787
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 23886052
BUSINESS ADDRESS:
STREET 1: 590 MADISON AVENUE 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-521-4379
MAIL ADDRESS:
STREET 1: 590 MADISON AVENUE 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valence Investments SPV V, LLC
CENTRAL INDEX KEY: 0001854361
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 23886053
BUSINESS ADDRESS:
STREET 1: 590 MADISON AVENUE 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-521-4379
MAIL ADDRESS:
STREET 1: 590 MADISON AVENUE 21ST FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CalciMedica, Inc.
CENTRAL INDEX KEY: 0001534133
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452120079
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-952-5500
MAIL ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: CalciMedica, Inc. /DE/
DATE OF NAME CHANGE: 20230322
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG VISION, INC.
DATE OF NAME CHANGE: 20170717
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG, Inc.
DATE OF NAME CHANGE: 20150303
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-20
0
0001534133
CalciMedica, Inc.
CALC
0001812080
Valence Investments SPV IV LLC
590 MADISON AVENUE 21ST FLOOR
NEW YORK
NY
10022
0
0
1
0
0001854361
Valence Investments SPV V, LLC
590 MADISON AVENUE 21ST FLOOR
NEW YORK
NY
10022
0
0
1
0
0001971787
Valence Investments SPV VI, LLC
590 MADISON AVENUE 21ST FLOOR
NEW YORK
NY
10022
0
0
1
0
0
Common Stock
2023-03-20
4
A
0
356989
A
356989
D
Common Stock
2023-03-20
4
A
0
66228
A
66228
I
By Valence Investments SPV V, LLC
Common Stock
2023-03-20
4
A
0
316109
A
316109
I
By Valence Investments SPV VI, LLC
Warrant
27.94
2023-03-20
4
A
0
9935
A
2026-02-22
Common Stock
9935
9935
I
By Valence Investments SPV V, LLC
Warrant
27.94
2023-03-20
4
A
0
9935
A
2026-06-25
Common Stock
9935
9935
I
By Valence Investments SPV V, LLC
Received in exchange for an aggregate of 12,395,423 shares of common stock of CalciMedica, Inc. ("CalciMedica") pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among CalciMedica, the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer ("Merger Sub"). Under the terms of the Merger Agreement, on March 20, 2023, Merger Sub merged with and into CalciMedica (the "Merger"), with CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc.
Received in exchange for 2,299,564 shares of the common stock of CalciMedica pursuant to the Merger Agreement.
Received in exchange for 10,975,977 shares of the common stock of CalciMedica pursuant to the Merger Agreement.
Immediately exercisable.
Received in exchange for a warrant to acquire 344,934 shares of common stock of CalciMedica pursuant to the Merger Agreement.
Valence Investments SPV IV, LLC, by /s/ Eric Roberts, Manager
2023-05-03
Valence Investments SPV V, LLC, by /s/ Eric Roberts, Manager
2023-05-03
Valence Investments SPV VI, LLC, by /s/ Eric Roberts, Manager
2023-05-03